TY  - GEN
AU  - Gunther,R
AU  - Chelstrom,L M
AU  - Tuel-Ahlgren,L
AU  - Simon,J
AU  - Myers,D E
AU  - Uckun,F M
TI  - Biotherapy for xenografted human central nervous system leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin
SN  - 0006-4971
PY  - 1995///0531
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antigens, CD
KW  - immunology
KW  - Antigens, CD19
KW  - Antigens, Differentiation, B-Lymphocyte
KW  - Blood-Brain Barrier
KW  - Bone Marrow
KW  - pathology
KW  - Cell Movement
KW  - Central Nervous System
KW  - DNA, Neoplasm
KW  - analysis
KW  - Drug Evaluation, Preclinical
KW  - Immunotoxins
KW  - Injections, Intraperitoneal
KW  - Injections, Intravenous
KW  - Injections, Spinal
KW  - Leukemic Infiltration
KW  - drug therapy
KW  - Meninges
KW  - Methotrexate
KW  - therapeutic use
KW  - Mice
KW  - Mice, SCID
KW  - N-Glycosyl Hydrolases
KW  - Neoplasm Transplantation
KW  - Neoplastic Cells, Circulating
KW  - Plant Proteins
KW  - Polymerase Chain Reaction
KW  - Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - Ribosome Inactivating Proteins, Type 1
KW  - Specific Pathogen-Free Organisms
KW  - Transplantation, Heterologous
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
ER  -